John Theurer Cancer Center at Hackensack UMC (Site 128) — Hackensack, New Jersey

John Theurer Cancer Center at Hackensack UMC (Site 128) is a clinical research site located in Hackensack, New Jersey, United States 07601.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

John Theurer Cancer Center at Hackensack UMC (Site 128) has participated in 1 clinical trials.

Therapeutic areas: Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL.

Sponsors: Ariad Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for John Theurer Cancer Center at Hackensack UMC (Site 128)?

John Theurer Cancer Center at Hackensack UMC (Site 128) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has John Theurer Cancer Center at Hackensack UMC (Site 128) conducted?

John Theurer Cancer Center at Hackensack UMC (Site 128) has 1 clinical trials on record. Their work covers Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL.

Is John Theurer Cancer Center at Hackensack UMC (Site 128) accredited by Crixeo Health?

John Theurer Cancer Center at Hackensack UMC (Site 128) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about John Theurer Cancer Center at Hackensack UMC (Site 128)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.